WCLC 2022 | Targeting KRAS in lung cancer

Jong Woo Lee, MD, PhD, Yale Cancer Center and Yale University School of Medicine, New Haven, CT, talks on targeting KRAS in lung cancer. Based on research, combining Aurora Kinase A (ARUKA) inhibition with WEE1 inhibition can potentiate the inhibition of KRAS in lung cancer. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.